(Q39085489)

8 September 2017

0 references

CYD-TDV dengue vaccine: systematic review and meta-analysis of efficacy, immunogenicity and safety (English)

1 reference

8 September 2017

0 references

1 reference

1 reference

Isabella Piassi Godói

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28084784%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Livia Lovato Pires Lemos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28084784%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Vânia Eloisa de Araújo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28084784%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Braúlio Cesar Bonoto

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28084784%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Brian Godman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28084784%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Augusto Afonso Guerra Júnior

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28084784%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

13 January 2017

1 reference

Journal of Comparative Effectiveness Research

8 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28084784%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28084784%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28084784%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

165-180

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28084784%20AND%20SRC:MED&resulttype=core&format=json

The global distribution and burden of dengue

10 June 2020

cites work

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Refining the global spatial limits of dengue virus transmission by evidence-based consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Dengue infection in neotropical forest mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Safety, immunogenicity and efficacy of a recombinant tetravalent dengue vaccine: a meta-analysis of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

New approaches to structure-based discovery of dengue protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

The global economic burden of dengue: a systematic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Assessing the Economics of Dengue: Results from a Systematic Review of the Literature and Expert Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Progress towards a dengue vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Next-generation dengue vaccines: novel strategies currently under development

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Long term persistence of yellow fever neutralising antibodies in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Dengue vaccines: strongly sought but not a reality just yet

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Preparing for dengue vaccine introduction: recommendations from the 1st dengue v2V International Meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Rational design of a live attenuated dengue vaccine: 2'-o-methyltransferase mutants are highly attenuated and immunogenic in mice and macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Genetic and phenotypic characterization of manufacturing seeds for a tetravalent dengue vaccine (DENVax).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Induction of neutralizing antibodies against four serotypes of dengue viruses by MixBiEDIII, a tetravalent dengue vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Safety and immunogenicity of three tetravalent dengue vaccine formulations in healthy adults in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Immunogenicity and safety of a recombinant tetravalent dengue vaccine in children and adolescents ages 9-16 years in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Safety and immunogenicity of a recombinant tetravalent dengue vaccine in 9-16 year olds: a randomized, controlled, phase II trial in Latin America.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2-45 y: Phase II randomized controlled trial in Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Immunogenicity and safety of tetravalent dengue vaccine in 2-11 year-olds previously vaccinated against yellow fever: randomized, controlled, phase II study in Piura, Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Safety and immunogenicity of a tetravalent dengue vaccine in healthy children aged 2-11 years in Malaysia: a randomized, placebo-controlled, Phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Efficacy of a tetravalent dengue vaccine in children in Latin America.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Dengue vaccines: progress and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Flavivirus-induced antibody cross-reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Dengue virus neutralizing antibody levels associated with protection from infection in thai cluster studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

GeoSentinel surveillance of illness in returned travelers, 2007-2011

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Dengue Sentinel Traveler Surveillance: Monthly and Yearly Notification Trends among Japanese Travelers, 2006-2014

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Role of vaccine manufacturers in developing countries towards global healthcare by providing quality vaccines at affordable prices

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

Pharmaceutical industry sponsorship and research outcome and quality: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FCER-2016-0045

21 January 2018

Identifiers

DOI

10.2217/CER-2016-0045

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28084784%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1 reference